Home » FDA Amends Labeling Requirements for NSAID Warnings
FDA Amends Labeling Requirements for NSAID Warnings
November 25, 2009
Manufacturers of OTC acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) do not have to put a warning about acetaminophen’s risk of liver
injury and NSAID-related stomach bleeding on each blister unit of a blister card, according to an amended final rule.